These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3707628)

  • 1. Further evidence for the lack of association between acetylator phenotype and systemic lupus erythematosus.
    Baer AN; Woosley RL; Pincus T
    Arthritis Rheum; 1986 Apr; 29(4):508-14. PubMed ID: 3707628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acetylator phenotype in idiopathic systemic lupus erythematosus.
    Reidenberg MM; Levy M; Drayer DE; Zylber-Katz E; Robbins WC
    Arthritis Rheum; 1980 May; 23(5):569-73. PubMed ID: 7378086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Normal distribution of acetylation phenotypes in systemic lupus erythematosus.
    Vansant J; Woosley RL; John JT; Sergent JS
    Arthritis Rheum; 1978 Mar; 21(2):192-5. PubMed ID: 637885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acetylator phenotype in Iraqi patients with systemic lupus erythematosus.
    Najim RA; Farid YY; Samad TA; Shihab SA
    East Mediterr Health J; 2005; 11(5-6):1003-8. PubMed ID: 16761671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The lack of relationship between acetylator phenotype and idiopathic systemic lupus erythematosus in a South-east Asian population: a study of Indians, Malays and Malaysian Chinese.
    Ong ML; Mant TG; Veerapen K; Fitzgerald D; Wang F; Manivasagar M; Bosco JJ
    Br J Rheumatol; 1990 Dec; 29(6):462-4. PubMed ID: 2257457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acetylator phenotype in systemic lupus erythematosus.
    Foad B; Litwin A; Zimmer H; Hess EV
    Arthritis Rheum; 1977 Apr; 20(3):815-8. PubMed ID: 301027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isoniazid disposition, comparison of isoniazid phenotyping methods in and acetylator distribution of Japanese patients with idiopathic systemic lupus erythematosus and control subjects.
    Horai Y; Ishizaki T; Sasaki T; Koya G; Matsuyama K; Iguchi S
    Br J Clin Pharmacol; 1982 Mar; 13(3):361-74. PubMed ID: 7059436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug acetylation and expression of lupus erythematosus.
    Marsden JR; Mason GG; Coburn PR; Rawlins MD; Shuster S
    Eur J Clin Pharmacol; 1985; 28(4):387-90. PubMed ID: 4029245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No demonstrable relationship between IgM and IgG antinuclear antibody levels and acetylator phenotype in patients with systemic lupus erythematosus.
    Portanova JP; Small CJ; Kohler PF
    Arthritis Rheum; 1985 Sep; 28(9):995-8. PubMed ID: 3899125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug acetylation phenotype unrelated to development of spontaneous systemic lupus erythematosus.
    Morris RJ; Freed CR; Kohler PF
    Arthritis Rheum; 1979 Jul; 22(7):777-80. PubMed ID: 454504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphic acetylator phenotype and systemic lupus erythematosus.
    Johansson E; Mustakallio KK; Mattila MJ
    Acta Med Scand; 1981; 210(3):193-6. PubMed ID: 6974957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The acetylator phenotype of patients with systemic lupus erythematosus.
    Reidenberg MM; Martin JH
    Drug Metab Dispos; 1974; 2(1):71-3. PubMed ID: 4150137
    [No Abstract]   [Full Text] [Related]  

  • 13. Acetylator phenotype and lupus erythematosus.
    Uetrecht JP; Woosley RL
    Clin Pharmacokinet; 1981; 6(2):118-34. PubMed ID: 7011656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acetylator phenotype in spontaneous SLE and rheumatoid arthritis.
    Lawson DH; Henry DA; Lowe J; Reavey P; Rennie JA; Solomon A
    Ann Rheum Dis; 1979 Apr; 38(2):171-3. PubMed ID: 443884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acetylation phenotypes and environmental chemical exposure of people with idiopathic systemic lupus erythematosus.
    Reidenberg MM; Drayer DE; Lorenzo B; Strom BL; West SL; Snyder ES; Freundlich B; Stolley PD
    Arthritis Rheum; 1993 Jul; 36(7):971-3. PubMed ID: 8318043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of association between slow acetylator status and spontaneous lupus erythematosus.
    Kumana CR; Chan MM; Wong KL; Wong RW; Kou M; Lauder IJ
    Clin Pharmacol Ther; 1990 Aug; 48(2):208-13. PubMed ID: 2379389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetically determined variability in acetylation and oxidation. Therapeutic implications.
    Clark DW
    Drugs; 1985 Apr; 29(4):342-75. PubMed ID: 2859977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydralazine-induced systemic lupus erythematosus: influence of HLA-DR and sex on susceptibility.
    Batchelor JR; Welsh KI; Tinoco RM; Dollery CT; Hughes GR; Bernstein R; Ryan P; Naish PF; Aber GM; Bing RF; Russell GI
    Lancet; 1980 May; 1(8178):1107-9. PubMed ID: 6103441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acetylator phenotype and metabolic disposition of isoniazid in Japanese patients with systemic lupus erythematosus.
    Ishizaki T; Horai Y; Koya G; Matsuyama K; Iguchi S
    Arthritis Rheum; 1981 Oct; 24(10):1245-54. PubMed ID: 7306226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cigarette smoking, N-acetyltransferase 2 polymorphisms and systemic lupus erythematosus in a Japanese population.
    Kiyohara C; Washio M; Horiuchi T; Tada Y; Asami T; Ide S; Takahashi H; Kobashi G;
    Lupus; 2009 Jun; 18(7):630-8. PubMed ID: 19433464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.